Difficulty Achieving Vitamin D Sufficiency With High-Dose Oral Repletion Therapy in Infants With Cholestasis. Issue 2 (August 2015)

• Record Type: Journal Article
• Authors: Jensen, Melissa; Abu-El-Haija, Maisam; Bishop, Warren; Rahhal, Riad M.
• Is Part Of: Journal of pediatric gastroenterology and nutrition. Volume 61:Issue 2(2015)
• Publication Date: 2015-08
• Subjects: Children -- Nutrition -- Periodicals; Pediatric gastroenterology -- Periodicals; Infants -- Nutrition -- Periodicals; Nutrition disorders in children -- Periodicals; Child Nutrition -- Periodicals; Digestive System -- growth & development -- Periodicals; Gastrointestinal Diseases -- Periodicals; Infant Nutrition -- Periodicals; Nutrition Disorders -- Periodicals; Child; 618.923
• DOI: 10.1097/MPG.0000000000000751
• Languages: English
• ISSNs: 0277-2116

Abstract

<abstract> <title>ABSTRACT</title> <sec> <title>Objectives:</title> <p>Oral high-dose repletion vitamin D therapy, also known as stoss therapy, can be effective in the treatment of nutritional vitamin D deficiency rickets in infants and young children without liver disease and in patients with cystic fibrosis. There is no literature about this approach in infants with new-onset cholestasis.</p> </sec> <sec> <title>Methods:</title> <p>This was a retrospective chart review of infants with cholestasis from March 2010 to March 2012 at a pediatric tertiary care center. Four cases satisfied the inclusion criteria, and were described in detail.</p> </sec> <sec> <title>Results:</title> <p>All of the patients received oral high-dose repletion therapy with ergocalciferol (vitamin D₂) 300, 000 IU daily for 2 to 3 days. Follow-up vitamin D levels approximately 4 weeks later showed failure to achieve sufficiency levels (&gt;20 ng/dL) in any patient.</p> </sec> <sec> <title>Conclusions:</title> <p>Unlike infants without liver disease, use of oral high-dose repletion therapy may not be adequate as treatment of vitamin D deficiency in the setting of cholestasis.</p> </sec> </abstract>